February 18, 2015
This Fast-Track SBIR project will provide ABT with the funding needed to fully demonstrate and validate our unique integrated ability to automatically synthesize and perform QC testing of on-demand low-cost doses of [18F]FLT, and thus greatly expand the ability to monitor and diagnose tumor proliferation.
The funding associated with this grant will enable ABT to develop and procure new Chemistry Production Modules (CPMs), and a dedicated cyclotron test bed for future F-18 tracer development. The architecture of the [18F]FLT CPM will also be used for future [18F]F-Choline development.
This SBIR Grant validates the confidence of the Healthcare Industry in ABT’s technology, and Synthesis and QC methodology, and will enable us to deliver new functionality and flexibility to our valued customers.
Disclaimer: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number 1R44CA195813-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
